Bausch Health Companies Inc. Stock
A very strong showing by Bausch Health Companies Inc. today, with an increase of €0.18 (3.410%) compared to yesterday's price.
Our community identified positive and negative aspects for Bausch Health Companies Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Bausch Health Companies Inc. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bausch Health Companies Inc. in the next few years
Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bausch Health Companies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc. | 3.410% | -1.914% | 22.024% | 3.808% | -15.832% | -37.773% | -77.393% |
| Opko Health Inc. | 2.680% | -2.542% | -10.156% | 10.619% | 5.485% | -35.262% | -63.492% |
| Repligen Corp. | 2.170% | 12.019% | 11.929% | 43.897% | -1.739% | -11.282% | -35.115% |
| China Traditional Chinese Medicine Co Ltd | 0.000% | 0.000% | 0.000% | -3.509% | 0.917% | -45.813% | -55.645% |
Comments
Bausch Health Cos (NYSE:BHC) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Jefferies Financial Group Inc. from $13.00 to $9.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BHC provided by MarketBeat